Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00677053 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes

A Phase 2 study of Acute Coronary Syndrome, sponsored by Takeda.

Completed
Registry status
Phase 2
Development phase
2,753
Enrollment target
20
Study locations

NCT00677053 is a Phase 2 study of Acute Coronary Syndrome that has completed, run by Takeda. The registered enrollment target is 2,753 participants, roughly in line with the 2,653-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target. The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00677053, a Phase 2 study of Acute Coronary Syndrome, has completed, sponsored by Takeda.

COMPLETED
Registry status
Phase 2
Development phase
2,753 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine the safety and tolerability of multiple doses of TAK-442once daily, (QD) or twice daily (BID), in subjects with acute coronary syndrome (unstable angina, myocardial infarction).

Conditions Studied

Acute Coronary Syndrome

Interventions

  • DRUG TAK-442

Study Locations (20)

Other

  • - Buenos Aires
  • - Bonheiden
  • - Genk
  • - Liège
  • - Porto Algere

Texas

  • - Houston
  • - Victoria

Alabama

  • - Birmingham

Arizona

  • - Tucson

Delaware

  • - Newark

District of Columbia

  • - Washington D.C.

Florida

  • - Pensecola

Iowa

  • - West Des Moines

Trial Details

FieldValue
Enrollment Target 2,753 participants
Start Date 2008-03
Est. Completion 2010-06
Phase Phase 2

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00677053

The ClinicalTrials.gov registry entry for NCT00677053 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,753 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,653-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which TAK-442 is the first listed.

NCT00677053 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Other, Texas, Alabama.

Frequently Asked Questions

What is clinical trial NCT00677053 about?

NCT00677053 is a clinical study titled "Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes". The purpose of this study is to determine the safety and tolerability of multiple doses of TAK-442once daily, (QD) or twice daily (BID), in subjects with acute coronary syndrome (unstable angina, myocardial infarction).

What is the current status of trial NCT00677053?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,753 participants. The study started on 2008-03. Estimated completion is 2010-06.

What conditions does trial NCT00677053 study?

This clinical trial studies the following conditions: Acute Coronary Syndrome.

What interventions are being tested in trial NCT00677053?

The interventions under investigation include: TAK-442 (DRUG).

Who is sponsoring clinical trial NCT00677053?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00677053 being conducted?

This trial has 20 study locations across Alabama, Arizona, Delaware, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Coronary Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Coronary Syndrome

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.